EU BSE risk material ban two-year exemption proposed by European Commission.
This article was originally published in The Tan Sheet
Executive Summary
EU BSE RISK MATERIAL PROPOSAL WOULD ALLOW TWO-YEAR EXEMPTION for "medicinal products" already on the market to eliminate use of "specified risk materials" for transmissible spongiform encephalopathies (including bovine SEs, often called "mad cow" disease). "For medicinal products for which few or no satisfactory therapeutic alternatives exist, a member state may allow the use of SRM until an alternative is developed, but at the latest until Dec. 31, 1999," the European Union said Dec. 3. Use of SRM in new products will be banned in the EU beginning Jan. 1 under a July European Commission decision.